Fig. 13From: Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemiaCMap analysis results for low and high SRP14 phenotypes in TCGA cohort. a phenazone; b benzydamine; c cinnarizine; d antazoline; and e CMap analysis resultsBack to article page